Regulatory and drug-pricing worries have knocked biotech stocks off their Covid pedestal. After seeing massive gains in 2020 amid the Covid-19 vaccine heyday and hitting [...] The post Biotech Stocks Hit A Snag — Why Experts Say The Heyday Isn’t Over first appeared on PRP Breaking News and Top Stories.
http://dlvr.it/RxMYZH
No comments:
Post a Comment